Phase 2 Chronic Rhinosinusitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are an adult (aged 18 to under 80) who has been diagnosed with chronic rhinosinusitis (a long-term sinus condition) by an ear, nose and throat (ENT) specialist.
- You are currently receiving the maximum recommended medical treatment for your sinus condition as part of your normal care.
- You have had sinus surgery (called FESS – a procedure to open up the sinuses using a small camera) at least 6 months before joining the study.
- A camera examination of your nose has shown that any nasal polyps (small growths inside the nose) are small to moderate in size — not completely blocking your nasal passage.
- The examination has confirmed that key parts of your sinuses are visible and accessible for treatment.
- You rate your condition as more than 2 out of 10 on a symptom severity scale at the time of screening.
- You weigh at least 40 kg and have a BMI of 39 or below at the screening visit.
- If you are able to become pregnant, you must be willing to use a reliable form of contraception and not plan to become pregnant during the study.
- You are willing and able to give written consent and follow all study requirements.
Who may not be able to join:
- You have a known allergy or sensitivity to betamethasone dipropionate, mometasone, or local anaesthetic agents (medicines used in this treatment).
- You have nasal or sinus abnormalities, other nasal conditions, or implanted devices in the nose/sinuses that would prevent the treatment from being given.
- You have previously taken part in this same study.
- You are currently taking, or have taken in the past 4 weeks, steroid tablets or injections that work throughout your whole body, or you are currently receiving biologic therapy (a type of medication that targets specific parts of the immune system).
- You have a history of glaucoma or cataracts, or your eye pressure was found to be higher than normal (above 21 mmHg) at your screening appointment.
- You currently have an acute (sudden or severe) sinus infection.
- You have a known problem with your immune system that reduces your ability to fight infections.
- You have Type 1 diabetes.
- You have cystic fibrosis.
- You are pregnant, trying to become pregnant, or currently breastfeeding, as the effects of this treatment on pregnancy are not yet known.
- You are unable to give informed consent due to mental illness, dementia, or difficulties with communication.
- You have been diagnosed with Cushing's disease (a hormonal condition) within the past 12 months.
- You have a severely deviated nasal septum (a significant bend in the wall between your nostrils) or have had a complete removal of a specific nasal structure called the middle turbinate.
- You have any abnormal test results or other health conditions that the study doctor feels would make participation unsuitable (confirm with trial site).
- The study doctor believes you are unlikely to be able to follow all study procedures and requirements.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +1 279-217-0054
Australian sites
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
4 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Change in 4-Cardinal Symptom score (4CSS) Baseline to Week 3.; Change in SNOT-22 Baseline to Week 3.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.